Yonsei University at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
Yonsei University takes part in 5 sessions at ESMO 2026 in Madrid. Its sessions centre on metastatic non-small cell lung cancer and gynaecological cancers, including platinum-resistant ovarian cancer and new systemic therapies for cervical cancer. Highlights include preventing skin side effects of subcutaneous amivantamab plus lazertinib in EGFR-mutant lung cancer, and a PD-L1 and VEGF-A bispecific antibody after chemoimmunotherapy.
| Organization | ESMO 2026 Attendance |
|---|---|
Yonsei University Seoul, Republic of Korea | |
Private research university in Seoul, South Korea, whose college of medicine runs Severance Hospital and a cancer centre. | Abstract Sat Oct 24 08:30–08:35 Abstract Sat Oct 24 08:40–08:45 Abstract Sun Oct 25 08:30–08:35 Talk Sun Oct 25 15:45–16:05 New developments in systemic therapy beyond CPIs in recurrent or metastatic disease Gynaecological cancers Abstract Mon Oct 26 10:47–10:52 |
Instantly find 20 buyers from Yonsei University
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction